Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

How CAR-Ts Are Changing The Lifecycle Paradigm For ATMPs

Jan 18 2019

• By Vibha Sharma

3d illustration of T cells or cancer cells — Existing Registries Can Be Used For Postmarket Studies On CAR-Ts • Source: Shutterstock

Related Content

First CAR T-Cell Therapies OK'd In EU: Novartis's Kymriah And Kite's Yescarta

Jun 29 2018

EMA Defines Actions For Using CAR-T Registries For Regulatory Evaluation

May 31 2018

EMA Outlines Regulatory Expectations On Use Of Patient Registries

Nov 13 2018

Additional Topics

Europe Regulation Drug Safety Regenerative Medicine BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window